Polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs) are widespread environmental contaminants that exist as complex mixtures and are frequently detected at part-per-trillion (ppt) levels in humans. Using isotope dilution high-resolution gas chromatography/ high-resolution mass spectrometry (HRGC/HRMS), we measure the PCDDs, PCDFs, and PCBs in serum of a population of 78 women residing in an area near Seveso, Italy where a TCDD explosion occurred in 1976 and where furniture is manufactured. The average total dioxin-like toxic equivalents (TEQ) of these women was 25.3 ppt, lipid-adjusted, comparable to other parts of Europe. TCDD levels, however, were higher among the few women who resided in the exposed area in 1976. We examined the possibility of using the CALUX (chemicalactivated luciferase gene expression) bioassay to estimate total TEQ in a small volume of plasma from this population. A total of 32 archived plasma specimens were selected for CALUX bioassay, based on the distribution of Total TEQ by HRGC/HRMS. The CALUX bioassay was performed blind to HRGC/HRMS results with 2 ml plasma per replicate analysis. Of 32 samples, 10 were below detection limits in the CALUX bioassay. For the 32 samples, the CALUX-TEQ averaged 25.4 ppt, lipid-adjusted (range: 0-127.6) and was not significantly different from the HRGC/HRMS Total TEQ average of 31.2 ppt, lipid-adjusted (range: 12.7-88.3) (t ¼ 0.88, P ¼ 0.38), however, the two measures were not significantly correlated (R s ¼ 0.04, P ¼ 0.82). More validation of the CALUX bioassay with larger sample volume is needed before application as an exposure measure in large-scale epidemiologic studies of health effects of dioxin-like compounds.
Introduction
Polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and biphenyls (PCBs) constitute a group of polyhalogenated aromatic hydrocarbons that are persistent, widespread environmental contaminants, frequently detected at the parts-per-trillion (ppt) level in lipid tissues of animals and humans (Zook and Rappe, 1994) . 2, 3, 7, is the most toxic congener within this group of compounds and has been associated with a wide variety of health effects including dermal, immunologic, carcinogenic, reproductive, developmental and endocrinologic effects in animals and humans (Birnbaum, 1994 (Birnbaum, , 1995 IARC, 1997) . It is believed that the mechanism of TCDD toxicity is via binding with the aryl hydrocarbon receptor (AhR) (Whitlock, 1993) . Several PCDDs, PCDFs, and PCBs have been shown to cause toxic effects similar to TCDD (IARC, 1997) . Like TCDD, these other dioxins and dioxinlike compounds bind to the AhR with a relative binding capacity that correlates with toxicity of effects (IARC, 1997) .
Since TCDD and other dioxin-like compounds exist as complex mixtures of various congeners throughout the environment, calculating total TCDD toxic equivalent (TEQ) concentration is the most relevant exposure measure in studies of health effects of dioxins and dioxin-like compounds (Van den Berg et al., 1998; Farland et al., 2000) . In particular, in background-exposed populations, these other congeners may contribute a large portion of TEQ relative to TCDD. Numerous exposure data have been published for residents of countries throughout the world, including Europe, North America, and Japan (Patterson et al., 1994; Papke 1998; Falk et al., 1999; Longnecker et al., 2000) . These data suggest there are regional differences in congener profiles of TEQ exposure and these differences may be due to variations in diet as well as area industrial sources.
The Seveso area of Italy, north of Milan, is a worldwide leading furniture-manufacturing area where potential for exposures exist from treated wood sawdust as well as the location of a historic TCDD explosion in 1976 (Mocarelli et al., 1988) . Despite these potential sources of TEQ exposure, the current exposure profile of TEQ congeners has not been described in this part of Italy.
To date, analytical methods to quantify exposure to these chemicals in biologic samples have included very sensitive and specific techniques such as isotope-dilution high-resolution gas chromatography/high-resolution mass spectrometry (HRGC/HRMS). However, these methods require relatively large sample volumes (B15 ml). Recently, an AhR-dependent recombinant bioassay was developed that can estimate the total TEQ concentration of a complex mixture in human serum Denison et al., 1996; Garrison et al., 1996) . The bioassay reportedly requires a relatively smaller sample volume (o5 ml).
The chemical-activated luciferase gene expression (CA-LUX) bioassay measures the ability of a chemical mixture to activate AhR-dependent gene expression of the firefly luciferase gene in genetically modified cell lines Denison et al., 1996; Garrison et al., 1996) . Two companies perform the CALUX bioassay with different cell lines and clean-up procedures. Xenobiotic Detection Systems (XDS) use a genetically engineered mouse cell line with a clean-up procedure that specifically isolates PCDDs and PCDFs from dioxin-like PCBs and estimates TEQ activity for each of these classes of dioxinlike chemicals (CALUX s by XDS). BioDetection Systems uses a genetically engineered rat cell line without separation of dioxin-like PCBs for estimation of TEQ activity (CALUX s by BDS). The CALUX s by BDS bioassay has been used to estimate serum TEQ in epidemiologic studies of endometriosis (Pauwels et al., 2001) , immunologic markers (Van Den Heuvel et al., 2002) , and sexual maturation Nawrot et al., 2002) . However, limited comparison studies of the CALUX s by BDS bioassay with the chemical analysis measurements have been completed (Pauwels et al., 2000; Koppen et al., 2001) . Two studies have been completed comparing the CALUX s by XDS bioassay with HRGC/ HRMS data (Kayama et al., 2001 (Kayama et al., , 2002 Van Wouwe et al., 2003) . While the results of these individual studies have reported significant correlations between CALUX-TEQ and chemical data (range of r ¼ 0.43-0.57), each study has used a different volume of serum for the CALUX bioassay (ranging from 1 to 10 ml) and variable chemical analysis methods (GC/ECD, GC/MS, HRGC/HRMS), not always measuring all relevant PCDDs, PCDFs, or PCB congeners (Pauwels et al., 2000; Kayama et al., 2001 Kayama et al., , 2002 Koppen et al., 2001; Van Wouwe et al., 2003) . Thus, while there is interest in using the CALUX bioassay as a measure of TEQ in epidemiologic studies, there is still a need to better define the parameters for its use, especially with respect to serum volume needed.
The purpose of this study is two-fold: to characterize current background exposure to PCDDs, PCDFs, and PCBs in the Seveso area of Italy, known for furniture manufacturing and the 1976 TCDD explosion based on HRGC/HRMS measurements; and to examine the correlation of these measurements with the CALUX s by XDS bioassay measure of TEQ in this population using a relatively small volume of plasma.
Methods

Study Population
Study participants included women who participated in an endometriosis case-control study at Desio Hospital, Italy, about 25 km north of Milan (Eskenazi et al., 2001) . To be eligible, a woman had to be 20-50 years old, and scheduled to undergo laparoscopy for pelvic pain, infertility, tubal ligation, or adnexal/uterine mass at the Hospital of Desio, between July 1998 and December 1999. As part of the study, women were interviewed by trained nurse-interviewers and asked about sociodemographic information, personal habits, and reproductive history. Because the Hospital of Desio was the hospital that followed the exposed residents after the 1976 TCDD explosion in Seveso (Mocarelli et al., 1988) and is located within 10 km of Seveso, we also asked in what exposure zone (A, B, R, non-ABR) (Mocarelli et al., 1992) they had resided at the time of the explosion. A total of 78 women provided a 70-ml blood sample. Informed consent was obtained from participants.
HRGC/HRMS Chemical Analysis
Serum samples were aliquoted and stored at À201C at Hospital of Desio. For each woman, a 15-ml serum sample was analyzed at US Centers for Disease Control and Prevention (CDC) for PCDDs, PCDFs, and PCBs by HRGC/HRMS (Patterson et al., 1987) . Serum samples were analyzed for the 17 PCDD/PCDF toxic congeners and coplanar PCBs (PCB 77, 81, 126, 169) . In addition, 36 PCBs were measured including the mono-ortho PCBs (PCB 105, 118, 156, 157, 167) . Serum total lipids were calculated using an enzymatic 'summation' method (Akins et al., 1989) . Values were reported on a lipid-weight basis in ppt for PCDDs, PCDFs, and coplanar PCBs, and parts per billion (ppb) for the 36 non-coplanar PCBs. To aid in the statistical analysis of data from truncated frequency distributions, quantifiable results less than the respective method detection limits were reported when observed for individual analytes. Individual analyte data with non-detectable values were assigned a value equal to one-half the detection limit for summary statistics of individual analyte concentration (Hornung and Reed, 1990 ).
CALUX Bioassay
Sample selection Based on the distribution of total TEQ data derived from the HRGC/HRMS data for the 78 women, we selected a total of 32 plasma samples (4 ml) to be sent in two shipments to Xenobiotic Detection System, Inc. (Durham, NC, USA) for CALUX s by XDS bioassay analysis. Specifically, we randomly selected eight samples per quartile of Total TEQ exposure, ranging from 12.5 ppt (reported detection limit of the CALUX bioassay based on 4 ml of plasma) to 88.3 ppt. Each shipment included samples from all four quartiles. XDS was blind to the HRGC/HRMS results.
Sample preparation Samples were prepared as described previously (Brown et al., 2002a (Brown et al., , 2002b . Briefly, plasma samples (4 ml) were processed to remove potential interfering compounds and to separate halogenated dioxin-like PCBs and halogenated dioxins/furans using XCARB affinity matrix (Brown et al., 2002a, b) . Plasma samples were transferred to hexane-rinsed glass 50 ml centrifuge tubes with PTFE-lined caps then shaken and extracted four times with an acetone/hexane mixture. The pooled extracts were evaporated under nitrogen and the dried residues were further cleaned up by suspension in hexane and application to an acid-silica column in series with an XCARB column containing activated carbon (Brown et al., 2002a, b) . The acid-silica column removes unwanted organic compounds including PAHs. The XCARB column was then differentially eluted to yield two fractions: a PCB fraction and a PCDD/ PCDF (DOX) fraction. For the CALUX s by XDS bioassay, a genetically engineered cell line is used, which contains the firefly luciferase gene under trans-activational control of the AhR (Garrison et al., 1996) . One half of the purified sample extracts (B2 ml) in DMSO were suspended in cell culture medium prior to dosing monolayers of H1L6.1 mouse hepatoma cells that were grown in 96-well culture plates and the analysis was replicated. In addition to the samples, a standard curve of TCDD was generated on each plate. The plates were incubated for optimal expression of luciferase activity in a humidified CO 2 incubator. After incubation, the medium was removed and the cells were examined microscopically for viability. The induced luciferase activity was quantified using the luciferase assay kit (Promega). The data for the TCDD standard curve were fit to a sigmoid curve described by the four parameter Hill equation using leastsquares best-fit modeling. CALUX-TEQ values were calculated for plasma samples by interpolation.
Statistical Analysis
Using the HRGC/HRMS data, TEQs were calculated separately for PCDDs (PCDD-TEQ), PCDFs (PCDF-TEQ), coplanar PCBs (cPCB-TEQ), mono-ortho PCBs (oPCB-TEQ) and Total TEQ, using the TEF scheme of the WHO (Van den Berg et al., 1998) . For calculations of TEQ, all nondetectable data were reassigned a value of zero.
In addition, REP-TEQs were estimated from CALUX s by XDS Relative Potency (REP) values instead of TEF values (Brown et al., 2001a) . CALUX s by XDS REPs are generally consistent with WHO-TEFs. Differences between REPS and TEFs appear to be related to the fact that WHO TEF values incorporate uptake and metabolism while these processes do not have a significant impact on the responsiveness of the CALUX bioassay (Brown et al., 2001a) .
Statistical analyses were performed using STATA 7.0 (Stata, 2001) . The distributions of individual PCDD, PCDF, and PCB congener data, as well as TEQ data, were initially examined graphically and with standard descriptive statistics. Analysis of variance was used to examine the relation of TEQ levels with covariates. Because these data were not normally distributed, the relationship between PCDD-TEQ, PCDF-TEQ, PCB-TEQ, Total TEQ, and CALUX-TEQ was examined by nonparametric correlation analysis. We considered these relations in three ways. First, we included the full sample (n ¼ 32) and assigned a value of zero to all CALUX non-detects. Second, we included the full sample (n ¼ 32) and assigned a value of one-half the detection limit to all CALUX non-detects. Third, we excluded CALUX non-detects from the analysis (n ¼ 22). We repeated the above analyses for just the DOX fraction of the CALUX bioassay results. We also repeated the above analyses for each CALUX batch separately. Finally, we examined the relation of CALUX-TEQ with TEQ estimated from CALUX s by XDS Relative Potency (REP) values (REP-TEQ) (Brown et al., 2001a) .
Results
The 78 women in the study were an average age of 36.3 years (SD ¼ 7.2), ranging from 20 to 49. The average body mass index was 22.7 mg/kg 2 (SD ¼ 3.8). A majority of the women were parous (n ¼ 44, 60%) and most had a history of lactation (n ¼ 31 of 44, 70%). From the sample of 78 women, we selected 32 samples for CALUX analysis. Descriptive characteristics of these 32 women were similar to the full sample (mean7SD age: 37.876.0 years, mean7SD BMI: 23.173.7 kg/m 2 , percent parous (n ¼ 22 of 32, 68%), history of lactation (n ¼ 22 of 22, 100%)).
In Table 1 , the results of serum HRGC/HRMS analysis are summarized for all 78 women. The average serum sample weight for the 78 women was 14.4 g serum. TCDD was detected in 19% of the samples with a median of 1.6 ppt, lipid-adjusted (range: 0.7-18.9). The four most prevalent analytes detected included octachlorodibenzodioxin (OCDD), 2, 3, 4, 7, 3, 4, 7, , 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl (PCB 126), and 3,3 0 ,4,4 0 ,5,5 0 -hexachlorobiphenyl (PCB 169), all of which were detected in more than 90% of samples. OCDD contributed the highest concentration of the dioxin congeners with a median of 292 ppt, lipid-adjusted. Among furans, the highest concentration was for 2,3,4,7,8-PCDF (median ¼ 10.9 ppt, lipid-adjusted). PCB 126 and PCB 169 were of similar median concentrations, 55.0 and 51.4 ppt, lipidadjusted, respectively.
As presented in Table 1 , the total TEQ for the study population averaged 25.3 ppt, lipid-adjusted (range: 0-88.3). In total, the percent contribution to Total TEQ by the four categories of compounds was similar, PCDDs (26.1%), PCDFs (25.3%), coplanar PCBS (27.3%), and mono-ortho PCBs (21.7%). The average TEQ values for the four categories of dioxin-like compounds that contribute to total TEQ (PCDDs (6.6 ppt), PCDFs (6.4 ppt), coplanar PCBs (6.9 ppt) and mono-ortho PCBs (5.5 ppt) were similar but a wider range was found for mono-ortho PCBs (0-73.7 ppt). The PCDD congeners contributing most to TEQ concentrations were 1,2,3,7,8-PCDD (mean ¼ 2.9 ppt TEQ), 2,3,7,8-TCDD (mean ¼ 1.6 ppt TEQ), and 1,2,3,4/6,7,8-HxCDD (mean ¼ 1.7 ppt TEQ). 2,3,4,7,8-PCDF (mean ¼ 5.7 ppt TEQ) contributed the most to PCDF-TEQ. The most dominant coplanar PCB contributing to PCB-TEQ was PCB 126 (mean ¼ 6.4 ppt TEQ), as reported by others (Kiviranta et al., 2002) . It is noteworthy that two congeners of mono-ortho PCBs (PCB 118, PCB 156) individually contributed more to total TEQ (mean ¼ 2.4 ppt and mean ¼ 3.1 ppt, respectively) than TCDD.
The relative percent contribution to Total TEQ by congeners of PCDDs, PCDFs, and PCBs for the group is presented in Figure 1 . TCDD contributes 4.5% to the total TEQ of this population. The major congeners that contribute to TEQ in this population are 1,2,3,7,8-PCDD (11.5%), 2,3,4,7,8-PCDF (25.1%), and PCB 126 (26.6%). Other notable congeners that contribute more than 5% to the total TEQ include 1,2,3,4/6,7,8-HxCDD (7.3%), 2,3 0 ,4,4 0 ,5-PeCB (PCB 118) (9.5%), and 2,3,3 0 ,4,4 0 ,5-HxCB (PCB 156) (7.5%).
We had information for 73 of the 78 women in this study on zone of residence at the time of the 1976 TCDD explosion in Seveso. The majority of women resided in the nonexposed area, Zone non-ABR (n ¼ 66, 90%), but seven women reported they lived in one of the exposed areas (Zone A (n ¼ 1); Zone B (n ¼ 2), Zone R (n ¼ 4)). The TCDD levels of the seven women from the exposed areas (median ¼ 4.3 ppt, range ¼ o2.3-18.9 ppt) were significantly higher than the 66 women from the nonexposed zone (median ¼ 1.5 ppt, range: o1.5-18.0 ppt) (P ¼ 0.002). Total TEQ levels, however, were not significantly different (Zones A, B, R (mean (range) ¼ 34.8 ppt (10.9-63.5)) versus Zone non-ABR (n ¼ 66, mean (range) ¼ 24.2 ppt (0.3-88.3)), P ¼ 0.11).
In univariate regression, total TEQ was higher among the 78 women who were older (P ¼ 0.01), married (P ¼ 0.01), parous (P ¼ 0.05), and had a history of lactation (P ¼ 0.02). In multivariate regression, however, only age remained a significant predictor of total TEQ in this population. CALUX s by XDS bioassay results for the two fractions (DOX and PCB) are described for each of the two shipments separately. For the first shipment of 16 samples, with 2 ml of sample extract, CALUX-TEQ for the DOX fraction was determined for three of the 16 samples. The remaining 13 of 16 samples were below the limit of quantification (LOQ) (NDo17 ppt, lipid-adjusted) in the CALUX s by XDS bioassay. For six of 13 nondetectable samples, however, the results were close enough to the LOQ level to estimate the CALUX-TEQ. For the remaining seven nondetectable samples, the average detection limit was 14.8 ppt, lipidadjusted. For the analysis of the PCB fraction, all 16 samples were nondetectable with an average detection limit of 20.4 ppt, lipid-adjusted. Replication of the analysis with the remaining 2 ml of sample extract was not possible due to bacterial contamination of the analytical plate.
For the second shipment of 16 samples, replication of the analysis with remaining sample extract was possible and results meeting optimal QA/QC criteria were reported. With 2 ml per sample, the CALUX-TEQ for the DOX fraction was determined for 13 of the 16 samples. The remaining three samples were nondetects in the CALUX s by XDS bioassay with an average detection limit of 12. Dioxin-like TEQ of Seveso womensamples were nondetectable with an average detection limit of 33.0 ppt, lipid-adjusted. We considered each shipment separately and together in the analysis and although the second shipment had fewer nondetects, the results were not different (data not shown). Because the results are similar for both shipments, the CALUX-TEQ results are summarized together. In Table 2 we present results in two ways: (1) including the full sample (n ¼ 32) but assigning CALUX (DOX fraction) nondetects a value of zero, and (2) excluding CALUX (DOX fraction) nondetects (n ¼ 22). For the full sample (n ¼ 32), the CALUX-TEQ averaged 25.4 ppt, lipid-adjusted (range: 0-127.6), not significantly different from the HRGC/HRMSderived total TEQ average of 31.2 ppt (range: 12.7-88.3) for the same 32 samples (t ¼ 0.88, P ¼ 0.38). Excluding nondetects (n ¼ 22), the CALUX-TEQ averaged 37.0 ppt, lipidadjusted (range: 1.6-127.6) and were not significantly different from the HRGC/HRMS-derived total TEQ of 31.9 ppt (range: 12.7-88.3) for the same 22 samples (t ¼ À0.62, P ¼ 0.54). For the 10 excluded non-detects, the HRGC/HRMS-derived total TEQ averaged 29.6 ppt, lipidadjusted (range 16.6-64.0).
As presented in Table 2 , for the full sample of 32, the nonparametric correlation (R s ) of CALUX-TEQ with HRGC/HRMS total TEQ was 0.04 (P ¼ 0.82). The highest correlations, although not significant, were found for PCDD TEQ (R s ¼ 0.34, P ¼ 0.06), PCDF TEQ (R s ¼ 0.25, P ¼ 0.17) and PCDD/PCDF TEQ (R s ¼ 0.31, P ¼ 0.09). When nondetects were excluded, the correlations did not change (PCDD R s ¼ 0.33, P ¼ 0.13; PCDF R s ¼ 0.15, P ¼ 0.50; PCDD/PCDF R s ¼ 0.24, P ¼ 0.28). We also examined the data assigning CALUX nondetects a value of one-half the detection limit, but the results were similar (data not shown).
Given that the CALUX PCB fraction was detected in only two of 32 samples, we also examined the relation of just the CALUX DOX fraction with the HRGC/HRMS data. For the full sample, the CALUX DOX fraction TEQ averaged 21.2 ppt (range: 0-67.3) compared with the HRGC/HRMSderived PCDD/PCDF TEQ average of 14.7 ppt (range: 5.2-49.1) (t ¼ À1.8, P ¼ 0.07). Excluding nondetects (n ¼ 22), the CALUX DOX fraction TEQ averaged 30.8 ppt (range: 1.6-67.3) and was significantly different from the HRGC/ HRMS-derived PCDD/PCDF TEQ average of 15.6 ppt (range: 5.2-49.1) (t ¼ À4.0, Po0.001). In Figure 2 , we graphically present the relationship of the CALUX DOX fraction TEQ versus HRGC/HRMS-derived PCDD/PCDF TEQ (R s ¼ 0.31, P ¼ 0.08). The results of correlation analysis of the CALUX DOX fraction TEQ versus HRGC/HRMS data did not differ from the CALUX-TEQ results (see Table 2 ).
We also considered the relation of the CALUX DOX fraction TEQ with TEQ estimated from CALUX s by XDS REP values instead of TEF values (REP-TEQ). REP values differ slightly from TEF values primarily because uptake and tissue distribution are not relevant to the response of the compounds for a cell-based bioassay (Brown et al., 2001a) . The total TEQ was reduced somewhat by applying the REP values to the HRGC/HRMS data. The Total REP-TEQ averaged 18.2 ppt (range: 7.4-55.0) for the full sample (n ¼ 32), and 18.9 ppt (range: 7.4-55.0) excluding the nondetects (n ¼ 22). Overall the results of correlation analysis were similar (data not shown). The nonparametric correlation of the CALUX DOX fraction TEQ with total REP-TEQ was 0.21 (P ¼ 0.24) and with PCDD/PCDF REP-TEQ was 0.31 (P ¼ 0.08). We calculated the sensitivity and specificity of the CALUX bioassay to correctly categorize HRGC/HRMS-derived total TEQ for a wide range of exposure cut-points (15, 20, 35, 40, 50, 60 ppt) . Sensitivity (range: 20-54%) and specificity (range: 50-93%) both varied across the range of exposure cut-points considered. The 15-ppt cut-point had the highest sensitivity (54%), but specificity was 50%.
As an additional test, three blind QA/QC 5-ml serum samples (NIST SRM 1589) were analyzed by the CALUX s by XDS bioassay (NIST, 2000) . The total TEQ for the samples based on HRGC/HRMS averaged 34.2 ppt, lipidadjusted (SD ¼ 3.4). The CALUX total TEQ reported for these three samples averaged 78.3 ppt (16.6, 91.7, and 126.7 ppt) .
Discussion
PCDD, PCDF and PCB concentrations measured in this study of women from the Seveso area of Italy were found to be comparable to body burdens reported in other background-exposed populations in industrial nations (Gonzalez et al., 1998; Papke 1998; Longnecker et al., 2000) . Also, the distribution of congeners was similar to that reported for other North American and European countries (Patterson et al., 1994; Papke 1998) with the four most prevalent analytes being OCDD, 2, 3, 4, 7, PCB 126, and PCB 169 . We also found the four categories of compounds (PCDD, PCDFs, coplanar PCBs, mono-ortho-PCBs) contributed a roughly similar percent to Total TEQ (B25%). TCDD contributed only 4.5% to the total TEQ of this population. It is noteworthy that two congeners of monoortho PCBs (PCB 118, PCB 156) individually contributed more to total TEQ than TCDD. Finally, consistent with that reported by others (Svensson et al., 1991; Patterson et al., 1994; Papke 1998; Kiviranta et al., 2002) , we found that age was a significant predictor of Total TEQ in this Italian sample.
In this study, the serum TCDD levels of the seven women who resided in exposed areas at the time of the 1976 explosion in Seveso were significantly higher than the women from the nonexposed area. This finding is consistent with the only other study of contemporary TCDD levels of Seveso residents (Landi et al., 1998) . Landi et al. (1998) measured TCDD levels in plasma collected in 1992-1994, from 30 women from exposed areas (Zones A and B) and 32 women from the nonexposed area (Zone non-ABR). The TCDD levels of the women in our study who resided in the nonexposed area (Zone non-ABR) in 1976 are comparable to those reported by Landi et al. (1998) . The TCDD levels of the women in 1998-1999 from the exposed areas, Zones A, B and R, (median ¼ 4.3 ppt), are lower than those reported by Landi et al. (median ¼ 16.8 ppt) in 1992 Landi et al. (median ¼ 16.8 ppt) in -1994 . However, four of the women in our study resided in Zone R, a zone that had less exposure than Zones A and B.
PCDDs, PCDFs, and PCBs exist as complex mixtures and have been shown to cause toxic effects similar to TCDD, thus it is important to include them in exposure assessment in studies of health effects of dioxin-like compounds. We examined the potential of using the CALUX bioassay to estimate TEQ in a small volume of plasma. We found no significant correlation between CALUX-TEQ and total TEQ or any TEQ measure derived from HRGC/HRMS data in this sample of Italian women with background exposure to dioxin and dioxin-like compounds. If more plasma were analyzed, the results may have improved. In a recent study in Belgium, using 10 ml serum for the CALUX s by XDS bioassay, a significant correlation between HRGC/MSderived PCDD/PCDF-TEQ and CALUX-TEQ (dioxin fraction only) of 0.71 was reported (Van Wouwe et al., 2003) . We found the use of a limited amount of plasma for the CALUX s by XDS bioassay resulted in a wide variation in the measure.
Previous studies using the CALUX s by BDS bioassay all report using 1-4 ml serum (Pauwels et al., 2000; Koppen et al., 2001 Koppen et al., , 2002 . However, in this study, using 2 ml of plasma per replicate analysis for the CALUX s by XDS bioassay, 31% of samples were not detectable for the PCDD/PCDF fraction and 94% of the samples were not detectable for the PCB fraction. Previous studies do not describe using as extensive a clean-up procedure as used in this study (Brown et al., 2002b) ; thus, it is possible that previous studies may be including in the measurement other nondioxin-like compounds that can bind to and activate the AhR (Schecter et al., 1999; Denison, 2000) . In fact, Pauwels et al. reported a significant correlation between CALUX-TEQ and the sum of four major PCB congeners (118, 138, 153, 180) that are non-dioxin-like (only PCB 118 has a TEF value of 0.0001) (r ¼ 0.43, Po0.001).
In this study, we found no evidence of a correlation between CALUX-TEQ and sum of the same four PCB congeners (R s ¼ 0.12, P ¼ 0.52). The CALUX bioassay can respond to a wide range of different compounds. Unlike chemical analysis methods, which measure the concentrations of specific compounds, the CALUX bioassay sums the effects of all compounds present in the sample extract that can bind to and activate the AhR. For a crude extract, this may include ''classical'' AhR ligands such as PCDDs, PCDFs, PCBs, polybrominated dibenzo-pdioxins, polybrominated dibenzofurans, polybrominated biphenyls, polybrominated diphenyl ethers, and some polyaromatic hydrocarbons, as well as ''nonclassical'' AhR ligands including bilirubin, tryptophan metabolites, and some corticosteroids (Denison and Heath-Pagliuso, 1998; Van Wouwe et al., 2003) . Because the CALUX bioassay cannot discriminate between these different active compounds, it is necessary to include sample clean-up procedures that can isolate the compounds of interest. Further, high levels of some PCBs have been shown to antagonize the dioxins if not separated (Garrison et al., 1996) . It has been reported that the TEQ value especially in samples containing relatively large amount of PCB 118 might be underestimated in the CALUX bioassay compared to an HRGC/HRMS determination (Bovee et al., 1998; Laier et al., 2003) . Inadequate sample clean-up prior to the CALUX bioassay might result in the measurement of activity due to these interfering compounds, and an inaccurate TEQ report for the sample (Brown et al., 2002b) . It is not clear as to what sample clean-up methods have been used in previous studies where higher correlations have been reported (Pauwels et al., 2000; Koppen et al., 2001 Koppen et al., , 2002 .
Because it has been thought that the CALUX bioassay could estimate exposure using smaller sample volumes and at lower cost, the CALUX bioassay has also been suggested as a screening assay to identify those samples that should be further analyzed by chemical analysis methods (Brown et al., 2001a) . In order for a screening assay to be useful, it should have high sensitivity at the expense of specificity. We found only moderate sensitivity (20-54%). Also, we have found that larger sample volumes may be necessary. The CALUX bioassay may be more appropriate as a screening tool for environmental samples that have higher levels of exposure than human serum, unless a larger volume of serum is used (Van Overmeire et al., 2000 Brown et al., 2001b; USEPA, 2002) .
In conclusion, we found using HRGC/HRMS that a population of 78 women from the Seveso area of Italy had an average TEQ of 25.3 ppt, lipid-adjusted, comparable to other parts of Europe, and that the levels of TCDD were higher in the few women who resided in the exposed area at the time of the 1976 TCDD explosion. We found that the HRGC/ HRMS method used to measure these compounds in 15 ml of serum, did not correlate well with the CALUX bioassay using 2 ml of plasma in this population. This finding points to the need for further validation before application of CALUX bioassay in large-scale epidemiologic studies. These results suggest that the amount of serum required for measuring background TEQ levels by the CALUX bioassay may be larger than previously thought and sample clean-up may also need to be a prerequisite to its application.
